BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank71
3Y CAGR-64.4%
Studio
Year-over-Year Change

Price to free cash flow ratio

3Y CAGR
-64.4%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
202515.72-40.2%
202426.27-90.9%
2023289.46-17.1%
2022348.96+300.3%
202187.18+128.7%
2020-304.00-94.3%
2019-156.44-29.1%
2018-121.18-62.0%
2017-74.79-104.6%
2016-36.55-